4.0 Editorial Material

Is There a Need for Immunopharmacologic Guidance of Anti-Tumor Necrosis Factor Therapies?

Journal

ARTHRITIS AND RHEUMATISM
Volume 63, Issue 4, Pages 867-870

Publisher

WILEY
DOI: 10.1002/art.30207

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available